DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ono Pharmaceutical
Ono Pharmaceutical
Nilotinib in Patients with Chronic Myeloid Leukemia: STAT2 Trial in Japan
Factset-Top Ten-0521.Xlsm
Research and Development in Breast Ultrasound E
Portfolio of Investments
JPX-Nikkei Index 400 Constituents (Applied on August 31, 2021) Published on August 6, 2021 No
TOBAM Maximum Diversification All World Developed Ex North America USD
TOPIX100 Constituents (As of October 31, 2019) No. Code Issue No. Code Issue 1 1605 INPEX CORPORATION 51 7201 NISSAN MOTOR CO.,LTD
R&Co Risk-Based Japan Index
Internet Disclosure Accompanying the Notice of Convocation the 117Th Ordinary General Meeting of Shareholders (Voluntary Disclosure)
Corporate Profile
Comprehensive List of Pharmaceuticals-Related Projects
Annex 1 No. of Constituents : 400 Annex 1. JPX-Nikkei Index 400 (As
Incorrect Email Address for Corresponding Author
The Impact of Molecular Subtype on Efficacy of Chemotherapy and Checkpoint Inhibition in Advanced Gastric Cancer
Stoxx® Asia/Pacific Climate Impact Ex Global Compact
1 August 27, 2018 Tokyo Stock Exchange, Inc
Stoxx True Exposure™ Japan 75% Index
CSHTGLP Composition
Top View
Phase III, Randomized, Placebo-Controlled, Double-Blind
Stoxx True Exposure™ Japan 75% Index
Do Profit Rate Differentials Diminish Over Time? a Statistical Analysis of Long-Term Financial Data
FTSE Blossom Japan Index
Additional File 1
Citi Pure Estimates Momentum Japan Long-Short Net TR Index (CIISEMJT)
Dow Jones Sustainability Asia Pacific Index
Corporate Report 2018
Annual Report 2019
Stoxx® Japan Strong Balance Sheet Equal Weight Index
DWS CROCI International
Lymphoma: a Single-Arm, Open-Label, Phase 2 Study
ICMJE Form for Disclosure of Potential Conflicts of Interest
Internet Disclosure Accompanying the Notice of Convocation the 118Th Ordinary General Meeting of Shareholders (Voluntary Disclosure)
Goldman Sachs Activebeta Japan Equity Index
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
TOPIX100 Constituents (As of October 31, 2017) No. Code Issue No. Code
TOPIX100 Constituents (As of October 30, 2015) No. Code Issue No
TOPIX100 Constituents (As of October 30, 2020) No. Code Issue No. Code Issue 1 1925 DAIWA HOUSE INDUSTRY CO.,LTD
Istoxx® Mutb Japan Proactive Leaders 200 Index
Corporate Report 2019
Japan Affiliate) Venue: Tower Hall Funabori Beyond the New Horizon: Implementation of the Global Standard 〒134-0091 4-1-1 Funabori Edogaw-Ku Tokyo
BNY Mellon | Adrs | Qualified Dividends for Tax Year 2020